Demonstrates Union Square Advisors’ extensive platform in providing comprehensive advisory services to leading companies in the Pharma Technology and HCIT space
On August 13, 2024, Union Square Advisors announced that it served as co-lead financial advisor to Array, a leading content engagement partner for life sciences events that offers a unique combination of data, technology and engagement services proven to enhance business results and drive actionable insights, in its August 5th, 2024 sale to WCG, the global leader in providing solutions that measurably improve the quality and efficiency of clinical research.
The acquisition will combine WCG’s industry-leading clinical research platform with Array’s content engagement solutions. This strategic move will leverage the strengths of both companies’ technology to provide a unique, integrated training solution, enabling sites, investigators and raters to successfully advance clinical research.
Together, WCG and Array’s integrated training solutions aim to accelerate start-up timelines, enhance quality and safety and alleviate the burden on sites and study teams, ultimately improving and saving lives through clinical research.
“For the past 20 years, we have been dedicated to making life science meetings and training more effective and engaging, with a focus on knowledge transfer. We are thrilled to join WCG to continue the important work of improving lives by accelerating clinical research together,” said Marc Crawford, chief executive officer, Array.
“Union Square Advisors is incredibly pleased to partner with the Array team as we continue to expand our presence and influence across the broad HealthTech landscape. Our collaboration underscores the depth and breadth of our strategic buyer relationships in the sector,” said Carter McClelland, Chairman at Union Square Advisors.
For more information, read the full press release here.
